David Nakasone
Head of Investigations
Replay available
Tarsus Pharmaceuticals, Inc. (TARS) Q3 2025 Earnings Call
Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) Q3 2025 earnings conference call, held 2025-11-04. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Bobby Azamian
Chief Executive Officer and Chairman
Aziz Madawala
Chief Commercial Officer
Jeff Farrow
Chief Financial Officer and Chief Strategy Officer
Andres Aguirre
Oppenheimer Analyst
Eddie Hickman
Guggenheim Analyst
Hanbury Brown
William Blair Analyst
Dennis Ding
Jefferies Analyst
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Tarsus Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.240 Good afternoon and welcome to TARCIS 3rd Quarter 2025 Financial Results Conference 00:00:05.240 -- 00:00:10.488 Call. As a reminder, this call is being recorded and all participants are on a listen-only 00:00:10.488 -- 00:00:14.635 mode. After the speaker's presentation, there will be a question and answer session. 00:00:14.635 -- 00:00:20.104 At this time, I would like to turn the call over to David Nakasone, 00:00:20.104 -- 00:00:22.408 Head of Investillations, to lead off the call. 00:00:22.408 -- 00:00:24.989 David, you may begin. 00:00:25.411 -- 00:00:29.616 Thank you. Before we begin, I encourage everyone to visit the investor section of the 00:00:29.616 -- 00:00:33.661 Tarsus website to view the earnings release and related materials we will be discussing 00:00:33.661 -- 00:00:38.788 today. Joining me on the call this afternoon are Bobby Azamian, our Chief Executive Officer 00:00:38.788 -- 00:00:43.774 and Chairman, Aziz Madawala, our Chief Commercial Officer, and Jeff Farrow, our Chief 00:00:43.774 -- 00:00:47.439 Financial Officer and Chief Strategy Officer. 00:00:47.439 -- 00:00:51.985 I'd like to draw your attention to slide three, which contains our forward-looking statements. 00:00:51.985 -- 00:00:55.498 During this call, we will be making forward-looking statements that are based on our 00:00:55.498 -- 00:01:00.544 current expectations and beliefs. These statements are subject to certain risks and 00:01:00.544 -- 00:01:04.448 uncertainties, and our actual results may differ materially. 00:01:04.448 -- 00:01:08.873 I encourage you to consult the risk factors contained in our SEC filings for additional 00:01:08.873 -- 00:01:13.379 detail. With that, I will turn the call over to Bobby. 00:01:13.379 -- 00:01:16.322 Good a...